Y Intercept (Hong Kong) LTD Insmed Inc Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$22.0 - $69.71 $340,560 - $1.08 Million
15,480 Added 206.07%
22,992 $1.54 Million
Q1 2024

May 10, 2024
SELL
$25.72 - $29.94 $456,735 - $531,674
-17,758 Reduced 70.27%
7,512 $203,000
Q4 2023

Feb 13, 2024
BUY
$23.42 - $31.74 $210,475 - $285,247
8,987 Added 55.19%
25,270 $783,000
Q3 2023

Nov 14, 2023
BUY
$19.86 - $26.93 $130,857 - $177,441
6,589 Added 67.97%
16,283 $411,000
Q2 2023

Aug 14, 2023
BUY
$16.44 - $21.1 $159,369 - $204,543
9,694 New
9,694 $204,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email